Persistent atrial fibrillation
Item
persistent atrial fibrillation
boolean
C2585653 (UMLS CUI [1])
Medical contraindication Omega-3 Fatty Acids | Hypersensitivity Omega-3 Fatty Acids
Item
contraindications or known hypersensitivity to n-3 pufa
boolean
C1301624 (UMLS CUI [1,1])
C0015689 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0015689 (UMLS CUI [2,2])
Omega-3 Fatty Acids
Item
current treatment with n-3 pufa for any reason
boolean
C0015689 (UMLS CUI [1])
Heart failure New York Heart Association Classification
Item
heart failure nyha class iv
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Coronary Artery Bypass Surgery | replacement; valve
Item
coronary artery bypass surgery or valve replacement within the past 3 months
boolean
C0010055 (UMLS CUI [1])
C1410969 (UMLS CUI [2])
Procedure on heart Planned
Item
planned cardiac procedures
boolean
C1279986 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Sick Sinus Syndrome
Item
known sick-sinus syndrome
boolean
C0037052 (UMLS CUI [1])
Wolff-Parkinson-White Syndrome
Item
diagnosis of wolff-parkinson-white
boolean
C0043202 (UMLS CUI [1])
Etiology Valves
Item
clinical significant valvular etiologies
boolean
C0015127 (UMLS CUI [1,1])
C1186983 (UMLS CUI [1,2])
Cardiac Arrhythmia Associated with Condition Reversible
Item
presence of arrhythmia associated with an acute reversible condition
boolean
C0003811 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C3843040 (UMLS CUI [1,3])
C0205343 (UMLS CUI [1,4])
Chronic lung disease Advanced
Item
advanced chronic lung disease
boolean
C0746102 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
Medical contraindication Anticoagulation Therapy
Item
contraindications for anticoagulation therapy
boolean
C1301624 (UMLS CUI [1,1])
C0003281 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Illness | Exception Heart Diseases | Life Expectancy
Item
any non cardiac illness associated with a life expectancy of < 2 years
boolean
C0221423 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0018799 (UMLS CUI [2,2])
C0023671 (UMLS CUI [3])
Investigational New Drugs
Item
treatment with any investigational agent within 3 month before randomization
boolean
C0013230 (UMLS CUI [1])
Condition compromises Treatment Effectiveness Evaluation | Condition compromises Evaluation Safety | Condition Protocol Compliance Poor
Item
any condition that in the opinion of the investigator would jeopardize the evaluation of efficacy or safety or be associated with poor adherence to the protocol
boolean
C0348080 (UMLS CUI [1,1])
C2945640 (UMLS CUI [1,2])
C0237602 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C2945640 (UMLS CUI [2,2])
C1261322 (UMLS CUI [2,3])
C0036043 (UMLS CUI [2,4])
C0348080 (UMLS CUI [3,1])
C0525058 (UMLS CUI [3,2])
C2700379 (UMLS CUI [3,3])